Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Non-Hodgkin's Lymphoma treatment details. Immunotherapy. Radiation. Korea Cancer Center Hospital, Seoul, Korea



Survival: 48.2 months
   
Toxicity Grade: 4
   
Treatments: Immunotherapy
Radiation
   
Drugs:
Country: Korea
   
City/State/Province: Seoul
   
Hospital: Korea Cancer Center Hospital
   
Journal: Link
   
Date: 4/2013

Description:
Patients:
This study involved 31 relapsed or refractory B cell non-Hodgkin lymphoma patients. The median patient age was 63 years and 68% were male.

Treatment:
Patients were given radioimmunotherapy with 131I-rituximab (the biologic therapy agent rituximab that is labeled with a radioactive molecule to cause cancer cell death).

Toxicities:
The most severe toxicities were of grade 4 and included neutropenia, thrombocytopenia, and anemia.

Results:
The median overall survival was 48.2 months.

Correspondence: Dr. Sang Moo Lim; email: smlim328@kcch.re.kr

E-mail to a Friend Email Physician More Information